original ) (raw )Sensitive quantification of omeprazole and its metabolites in human plasma by liquid chromatography–mass spectrometry
Ute Hofmann
Journal of Chromatography B, 2006
View PDFchevron_right
Determination of omeprazole in bulk and injectable preparations by liquid chromatography
Cleber Schmidt
Journal of AOAC International
View PDFchevron_right
A Simple RP-HPLC Method for the Determination of Omeprazole in Human Serum and Urine: Validation and Application in Pharmacokinetic Study
Mohammad Azad
Dhaka University Journal of Pharmaceutical Sciences, 2010
View PDFchevron_right
Improved high performance liquid chromatographic analysis of omeprazole in human plasma
Heena Abdul Raouf
View PDFchevron_right
A New Ultra Performance Liquid Chromatographic Method for Determination of Omeprazole in Capsule Dosage Form
Zehra Ertekin
Asian Journal of Chemistry, 2015
View PDFchevron_right
Analysis of omeprazole and 5-OH omeprazole in human plasma using hydrophilic interaction chromatography with tandem mass spectrometry (HILIC–MS/MS)—Eliminating evaporation and reconstitution steps in 96-well liquid/liquid extraction
qisheng song
Journal of Chromatography B, 2006
View PDFchevron_right
Enantiomeric Determination of Omeprazole and Esomeprazole by a Developed and Validated Chiral HPLC Method and Stability Studies by Microthermal Analysis
Dr. Md. Zakir Sultan
Dhaka University Journal of Pharmaceutical Sciences
View PDFchevron_right
Development and Validation of A Precise single HPLC Method For Determination of Omeprazole and its related compound in pharmaceutical formulation
Mukesh Patel
View PDFchevron_right
Improved procedure for quantitation of omeprazole and metabolites using reversed-phase high-performance liquid chromatography
Michael Amantea
Journal of Chromatography B: Biomedical Sciences and Applications, 1988
View PDFchevron_right
A Simple HPLC Method for the Determination of Omeprazole in Vitro
Tanveer ahmad
International Journal of Pharmaceutical Chemistry, 2013
View PDFchevron_right
Comparative Bioavailability Study of Two Oral Omeprazole Formulations after Single and Repeated Administrations in Healthy Volunteers
virginie gualano
Clinical Drug Investigation, 1998
View PDFchevron_right
Validation of an automated liquid chromatographic method for omeprazole in human plasma using on-line solid-phase extraction
S. Martin-puig
Journal of Pharmaceutical and Biomedical Analysis, 1999
View PDFchevron_right
Development and Validation of Omeprazole Analysis Methods in Capsules with Absorbance Methods and Areas under Curves Methods with UV-Vis Spectrophotometry
IJPSM Journal
IJPSM, 2018
View PDFchevron_right
Sensitive sulphur-specific detection of omeprazole metabolites in rat urine by high-performance liquid chromatography/inductively coupled plasma mass spectrometry
Lars Weidolf
Rapid Communications in Mass Spectrometry, 2004
View PDFchevron_right
Development and validation of RP-HPLC method for the estimation of omeprazole in bulk and capsule dosage forms
Mohammad Badrud Duza
International Current Pharmaceutical Journal, 2012
View PDFchevron_right
Simultaneous determination of omeprazole and their main metabolites in human urine samples by capillary electrophoresis using electrospray ionization-mass spectrometry detection
Ladan Tayebi
Journal of pharmaceutical and biomedical analysis
View PDFchevron_right
Simple and Fast Liquid Chromatography–Mass Spectrometry (LC–MS) Method for the Determination of Omeprazole, 5-hydroxyomeprazole, and Omeprazole Sulphone in Human Plasma
zafar Iqbal
Journal of Liquid Chromatography & Related Technologies, 2015
View PDFchevron_right
Validation of chromatographic methods: Evaluation of detection and quantification limits in the determination of impurities in omeprazole
Marcelo Ribani
Journal of Chromatography A, 2007
View PDFchevron_right
Plasma concentration-time profile of a single dose of enteric-coated omeprazole in male and female healthy volunteers
Tahir Tellioglu
MARMARA …, 2000
View PDFchevron_right
Bioequivalence and Pharmacokinetic Study of Two Different Omeprazole Capsule Formulations in Healthy Bangladeshi Volunteers
Ashraful islam
Arzneimittelforschung, 2011
View PDFchevron_right
Development and Validation of a RP‐HPLC Method to Quantify Omeprazole in Delayed Release Tablets
Rafael Pereira
Journal of Liquid Chromatography & Related Technologies, 2007
View PDFchevron_right
Chiral Separation of the Enantiomers of Omeprazole and Pantoprazole by Capillary Electrophoresis
Aura Rusu
Chromatographia, 2014
View PDFchevron_right
Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations
hoda mahgoub
Journal of Pharmaceutical and Biomedical Analysis, 2002
View PDFchevron_right
Relative Bioavailability of Two Enteric-Coated Formulations of Omeprazole following Repeated Doses in Healthy Volunteers
Dominik Hainzl , Luis Almeida
Clinical Drug Investigation, 2001
View PDFchevron_right
Evidence of human metabolites of omeprazole and its structure elucidation by using HPLC-MS
Mohammad Hailat
Journal of Molecular Structure, 2021
View PDFchevron_right
Population pharmacokinetics of omeprazole in a random Iranian population
Caspian Journal of Internal Medicine (CJIM)
Caspian Journal of Internal Medicine, 2013
View PDFchevron_right
New RP-HPLC Method for the Simultaneous Determination of Omeprazole and Aspirin in Bulk and Tablet Dosage Form
Gopal Krishna Padhy
2020
View PDFchevron_right
Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole
Tommy Andersson
Alimentary Pharmacology and Therapeutics, 2001
View PDFchevron_right
Zero order and area under curve spectrophotometric methods for determination of Omeprazole capsules in pharmaceutical formulation
Santosh Jadhav , Audumbar Mali
View PDFchevron_right
Determination of omeprazole in pharmaceuticals by derivative spectroscopy
Nuran Ozaltin
Journal of Pharmaceutical and Biomedical Analysis, 1997
View PDFchevron_right
Bioavailability of two single-dose oral formulations of omeprazole 20 mg: an open-label, randomized sequence, two-period crossover comparison in healthy Mexican adult volunteers
Jorge Luis Poo
Clinical therapeutics, 2008
View PDFchevron_right
Phenotype of CYP2C19 and CYP3A4 by determination of omeprazole and its two main metabolites in plasma using liquid chromatography with liquid–liquid extraction
VICTOR QUEZADA
Journal of Chromatography B, 2002
View PDFchevron_right